Integra LifeSciences Holdings (IART) Debt to Equity Ratio
Current and historical debt to equity ratio values for Integra LifeSciences Holdings (IART) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$3.921B||$0.992B|
|Integra LifeSciences Corp. develops, manufactures and markets medical devices, implants and biomaterials primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics and other surgical applications. Integra seeks to be the world's leading company specializing in implantable medical and biopharmaceutical therapies to target and control cell behavior, and to build shareholder value by acquiring, discovering, and developing cost-effective, off-the-shelf products that satisfy unmet medical needs.|